suramin sodium

DRUG2 trials

Sponsors

First Affiliated Hospital of Zhejiang University, Paxmedica

Conditions

Autism Spectrum DisorderHand, Foot and Mouth Disease

Phase 1

Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium

First Affiliated Hospital of Zhejiang UniversityHand, Foot and Mouth Disease

Start: 2018-12-19End: 2020-12-19Target: 36Updated: 2019-01-15

Phase 2

Double Blind Trial in Children With Autism Spectrum Disorder

CompletedNCT06058962

PaxmedicaAutism Spectrum Disorder

Start: 2019-06-01End: 2021-03-15Updated: 2023-11-13

Related Papers

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

Annals of General Psychiatry2023-11-065 citations